Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Trimebutine maleate

Trimebutine maleate

pharmaceutical raw materials
Trimebutine maleate structure

Trimebutine maleate 

structure
  • CAS No:

    34140-59-5

  • Formula:

    C22H29NO5.C4H4O4

  • Chemical Name:

    Trimebutine maleate

  • Synonyms:

    Benzoic acid,3,4,5-trimethoxy-,2-(dimethylamino)-2-phenylbutyl ester,(2Z)-2-butenedioate (1:1);Benzoic acid,3,4,5-trimethoxy-,β-(dimethylamino)-β-ethylphenethyl ester maleate (1:1);Benzoic acid,3,4,5-trimethoxy-,2-(dimethylamino)-2-phenylbutyl ester,(Z)-2-butenedioate (1:1);Trimebutine maleate;Debridat;Dromostat;TM 906;Spabucol;Cerekinon;Polibutin;Digerent;Foldox;Trimedat;Gast-Reg;39133-32-9

  • Categories:

    Active Pharmaceutical Ingredients  >  Anesthetic Agents

Description

Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects.Target: Opioid ReceptorTrimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain [1]. The major product from drug metabolism of trimebutine in human beings is nor-trimebutine, which comes from removal of one of the methyl groups attached to nitrogen. Trimebutine exerts its effects in part due to causing a


Trimebutine maleate is a trihydroxybenzoic acid.|Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Trimebutine maleate Basic Attributes

503.54200

503.21600

251-845-9

DKM38HXX5A|H4XZJ9GX7T

758900

DTXSID5046017

2922199090

Characteristics

131.83000

1.104g/cm3

105-106 °C

457.9ºC at 760mmHg

230.8ºC

1.610

2-8ºC

198.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

NONH for all modes of transport

2

R34

S26; S27; S36/37/39; S45

DI0360000

C

P201, P202, P261, P264, P270, P271, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501

H302

|Warning|H302 (16.67%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P261, P264, P270, P271, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 10 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)|Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)

Debridat

Trimebutine maleate Use and Manufacturing

Opioid receptor agonist. Antispasmodic Used as an intermediate in organic synthesis; used to treat gastrointestinal spasm, it is trimebutine maleate pex.

Computed Properties

Molecular Weight:503.5
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:12
Exact Mass:503.21553163
Monoisotopic Mass:503.21553163
Topological Polar Surface Area:132
Heavy Atom Count:36
Complexity:585
Undefined Atom Stereocenter Count:1
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

1. Regulating gastric motility: it can reduce the amplitude of gastric autonomic motility, increase the frequency and amplitude of irregular weak motility, and make it tend to be regular; 2. Inducing propulsive motility of the digestive tract system: it can induce physiological propulsive motility of the digestive tract in the adult digestive system; 3. Improving gastric emptying function: it can improve the weakened or hyperactive gastric emptying function of patients with chronic gastritis; 4. Regulating intestinal motility: it can regulate the muscle tension of colon specimens and inhibit the hypermotility of the large intestine caused by allergic enteritis syndrome; 5. Regulating the lower esophageal sphincter pressure (LESP): it can reduce the increase in internal pressure caused by tetragastrin load, and at the same time, it can also recover the decrease in internal pressure caused by secretin; 6. Direct effect on digestive tract smooth muscle: it still has a direct effect on digestive tract smooth muscle under various conditions, and can non-competitively inhibit the contraction caused by acetylcholine; 7. Terminal antiemetic effect: it has a significant inhibitory effect on vomiting induced by copper sulfate.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • XINHE YUANSHENG MEDICINE CO.,LTD.

    Japan Japan
    Active
  • EDMOND PHARMA S.r.l.

    Japan Japan
    Active
  • PMC ISOCHEM

    France France
    Active

Recommended Suppliers of Trimebutine maleate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.